Clinicians' guide to lipids and coronary heart disease
著者
書誌事項
Clinicians' guide to lipids and coronary heart disease
(Clinicians' guides)
Arnold , Oxford University Press [distributor], 2003
2nd ed
- タイトル別名
-
Lipids and coronary heart disease
大学図書館所蔵 件 / 全8件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
HTTP:URL=http://www.loc.gov/catdir/enhancements/fy0615/2003276398-d.html Information=Publisher description
HTTP:URL=http://www.loc.gov/catdir/enhancements/fy0615/2003276398-t.html Information=Table of contents only
内容説明・目次
内容説明
This fully updated revision of the well-received first edition continues to provide a clear, comprehensive and up-to-date account of the role of lipid management in the prevention of coronary heart disease. Appropriate for the clinician managing lipid problems in either the primary or secondary care setting, the well-respected author team consider all aspects of screening, diagnosis and risk assessment, and management. The science underlying lipid metabolism is put into context for the practising physician, including recent developments in inflammation, plaque biology and the transition to serious events. Risk factor modification, including lifestyle change and cholesterol lowerinig by diet and medication are discussed fully. Landmark clinical trials, and the messages that can be drawn from them, are highlighted throughout. The practical focus is maintained through the consideration of specific patient groups demonstrating particular clinical importance, management difficulties or highlighting areas of current controversy. With a balanced, readable style and clear explanatory illustrations, this second edition provides invaluable advice for primary care and specialist clinicians, whether in training or in practice, in the management of lipid disorders and the prevention of cardiovascular events.
目次
Part 1 Background
Lipid and lipoprotein metabolism - the basics
Epidemiology
Part 2 Screening and Assessment
Diagnosis
Screening
Risk factors and their assessment
Part 3 Intervention
Non-lipid risk factor modification
Diet
Lipid lowering drugs
Lipid lowering trials
Part 4 Practical considerations and special areas
Meeting the challenge
Special areas
Economic aspects
Case studies.
「Nielsen BookData」 より